BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8457789)

  • 1. Recombinant human erythropoietin and the anemia of multiple myeloma.
    Barlogie B; Beck T
    Stem Cells; 1993 Mar; 11(2):88-94. PubMed ID: 8457789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma].
    Haber J; Spicka I; Petruzelka L; Kolesková E; Straub J; Jonásová A; Pospísilová B
    Vnitr Lek; 1996 Apr; 42(4):262-7. PubMed ID: 8693713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human erythropoietin for the treatment of chronic anemia in multiple myeloma and squamous cell carcinoma.
    Ludwig H; Pecherstorfer M; Leitgeb C; Fritz E
    Stem Cells; 1993 Sep; 11(5):348-55. PubMed ID: 8241947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of the anemia of multiple myeloma: the role of recombinant human erythropoietin.
    Barlogie B
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):25-7. PubMed ID: 8153675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin treatment of anemia associated with multiple myeloma.
    Ludwig H; Fritz E; Kotzmann H; Höcker P; Gisslinger H; Barnas U
    N Engl J Med; 1990 Jun; 322(24):1693-9. PubMed ID: 2342535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human erythropoietin in a patient with multiple myeloma and end-stage renal disease.
    Holley JL; Nolan TA; Piraino B
    Clin Nephrol; 1992 Mar; 37(3):145-7. PubMed ID: 1563119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
    Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
    An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erythropoietin treatment of anemia associated with multiple myeloma (MM) and myelodysplastic syndrome (MDS)].
    Qiao ZH
    Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):122-4. PubMed ID: 8223121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Improvement of the anemia associated with multiple myeloma and renal dysfunction by recombinant human erythropoietin].
    Nakata H; Matsuzaki M; Shimamoto Y; Yamaguchi M
    Rinsho Ketsueki; 1990 Oct; 31(10):1752-3. PubMed ID: 2255069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of bone marrow cellularity during erythropoietin treatment in myeloma.
    Ludwig H; Chott A; Fritz E; Krainer M
    Stem Cells; 1995 Aug; 13 Suppl 2():77-87. PubMed ID: 8520516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phase II clinical study of recombinant human erythropoietin on the anemia associated with multiple myeloma].
    Urabe A; Mizoguchi H; Takaku F; Miyazaki T; Yachi A; Niitsu Y; Miura Y; Mutoh Y; Fujioka S; Nomura T
    Rinsho Ketsueki; 1993 Aug; 34(8):919-27. PubMed ID: 8411646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of erythropoietin in anemia of patients with immuno-lymphoproliferative disease].
    Longo G; Fiorani C; Bonacorsi G; Vanzanelli P; Sani F; Bevini M; Curci G; Torelli U
    Recenti Prog Med; 1992; 83(7-8):449-54. PubMed ID: 1529159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia in multiple myeloma.
    Ludwig H; Pohl G; Osterborg A
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):233-41. PubMed ID: 16163188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is erythropoietin treatment safe and effective in myeloma patients receiving hemodialysis?
    Caillette A; Barreto S; Gimenez E; Labeeuw M; Zech P
    Clin Nephrol; 1993 Sep; 40(3):176-8. PubMed ID: 8403574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
    Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
    J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anemia and hemostatic abnormalities associated with multiple myeloma].
    Aoki S; Shibata A
    Nihon Rinsho; 1995 Mar; 53(3):690-4. PubMed ID: 7699906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin therapy in cancer patients.
    Doweiko JP; Goldberg MA
    Oncology (Williston Park); 1991 Aug; 5(8):31-7; discussion 38, 43-4. PubMed ID: 1834151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human erythropoietin treatment of anemic cancer patients.
    Henry DH
    Cancer Pract; 1996; 4(4):180-4. PubMed ID: 8900758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recombinant erythropoietin (r-HuEPO) in the treatment of anemia in multiple myeloma].
    Spicka I; Haber J; Petruzelka L; Kolesková E; Sálková J; Straub J; Zounar R; Klener P
    Cas Lek Cesk; 1996 Jul; 135(14):450-3. PubMed ID: 8925545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of treatment of anemia with erythropoietin in patients with multiple myeloma].
    Adam Z; Krahulová M; Spelda S; Vorlícek J; Hejlová N; Hájek R; Tomíska M
    Vnitr Lek; 1995 Nov; 41(11):767-72. PubMed ID: 8553596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.